Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

This study has been completed.
Sponsor:
Collaborator:
St. Jude Medical
Information provided by:
Connolly, Stuart, M.D.
ClinicalTrials.gov Identifier:
NCT00257959
First received: November 22, 2005
Last updated: July 26, 2006
Last verified: November 2005

November 22, 2005
July 26, 2006
January 2001
Not Provided
ICD shock for any cause
Same as current
Complete list of historical versions of study NCT00257959 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
Not Provided

This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for spontaneous or inducible ventricular tachycardia or fibrillation

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Ventricular Tachycardia
Drug: amiodarone beta blocker sotalol
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
400
October 2004
Not Provided

Inclusion Criteria: spontaneous or inducible ventricular tachycardia or fibrillation -

Exclusion Criteria:

-

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00257959
1
Not Provided
Not Provided
Connolly, Stuart, M.D.
St. Jude Medical
Principal Investigator: Stuart Connolly McMaster University
Connolly, Stuart, M.D.
November 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP